Opportunities and challenges for TCR mimic antibodies in cancer therapy.

Monoclonal antibodies (mAbs) are potent cancer therapeutic agents, but exclusively recognize cell-surface targets whereas most cancer-associated prote...
418KB Sizes 1 Downloads 12 Views

Recommend Documents

No documents